aap Implantate AG
aap Implantate AG is a Berlin-headquartered, Frankfurt-listed medical device company that develops and markets LOQTEQ anatomical trauma plates and screws — including pipeline antibacterial silver-coated and resorbable magnesium variants — sold to hospitals and purchasing groups directly in Germany and through distributors in 25–41 countries.
- Company typePublic
- Founded1990
- HeadquartersBerlin, Germany
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What aap Implantate AG does
aap Implantate AG is a publicly listed German medical device company headquartered in Berlin (Lorenzweg 5, 12099 Berlin) that develops, manufactures, and markets trauma surgery implants, principally the LOQTEQ anatomical plate system and complementary cortical screws covering more than 95% of relevant indications in upper and lower extremity trauma. Its core proprietary technology, LOQTEQ, combines fracture compression and angle-stable locking in a single surgical step with polyaxial angulation up to 15° and variable compression from 0 to 2 mm, designed to minimize cold welding between screws and plates. Two pipeline platforms extend the brand: LOQTEQ antibacterial (silver-coated implants intended to reduce surgical-site infection, with a clinical human study successfully completed in August 2025) and LOQTEQ resorbable (magnesium-hydroxylapatite implants designed to degrade after healing, eliminating second-surgery removal).
Revenue is generated through hardware sales of LOQTEQ plates, screws, and ReproBone biomaterials. In Germany the company sells directly to hospitals, hospital purchasing groups (Einkaufsgemeinschaften), and network clinics (Verbundkliniken) via a field sales force of medical product consultants; internationally it relies on a distributor network spanning approximately 25–41 countries; and in the US it operates through wholly-owned subsidiary aap Implants Inc. (Dover, DE) using a hybrid of distribution agents, selective direct sales, and partnerships with global orthopedics companies. Reported FY2025 revenue was EUR 12.5 million (+2% YoY) with an EBITDA loss of EUR -0.64 million (improved from EUR -0.85M in FY2024), while the core Trauma segment achieved a positive recurring EBITDA of EUR 0.4 million. The portfolio is protected by international patents and holds CE/MDR (Class IIb certification completed Q1 2026), FDA, NMPA, and ANVISA approvals. The company is listed on the Frankfurt Stock Exchange General Standard (XETRA: AAQ.DE), with significant insider-linked shareholders Deepblue Holding AG and Merval AG participating in multiple recent capital increases.
aap Implantate AG firmographics
Firmographics- Name
- aap Implantate AG
- Legal name
- aap Implantate AG
- Website
- https://aap.de
- Company type
- Public
- Founded year
- 1990
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- aap Implantate AG is a Berlin-headquartered, Frankfurt-listed medical device company that develops and markets LOQTEQ anatomical trauma plates and screws — including pipeline antibacterial silver-coated and resorbable magnesium variants — sold to hospitals and purchasing groups directly in Germany and through distributors in 25–41 countries.
- Ownership category
- akta.pro rank
aap Implantate AG industry classification
Industry- Product category
- Orthopedic Trauma Implants
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB)
Keywords
Where aap Implantate AG is headquartered
LocationHeadquarters
- HQ city
- Berlin
- HQ country
- Germany
- HQ region
- Europe
Offices2 records
Markets served
aap Implantate AG business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Others
Revenue model
- Trauma Products - LOQTEQ® Plate System: Revenue from anatomical plate systems and screws for trauma surgery, sold directly in Germany and through distributors internationally.
- Trauma-Complementary Biomaterials: Revenue from trauma-complementary biomaterials marketed through distributor network globally.
Go-to-market motion3 records
Distribution channels3 records
Marketing channels5 records
aap Implantate AG product offering
Product offeringCore offering
aap Implantate AG develops, manufactures, and markets trauma surgery products, with its core portfolio built around the patented LOQTEQ anatomical plate system for fractures of the upper and lower extremities (shoulder, elbow, wrist, knee, ankle), complemented by cortical screws (Lochschrauben) and the ReproBone bone substitute biomaterial. The company also develops two next-generation platform technologies: LOQTEQ antibacterial silver-coated implants to prevent implant-related infections and LOQTEQ resorbable magnesium implants that biodegrade after fracture healing.
Product overview
aap Implantate AG is a medical technology company specializing in trauma surgery products. The product portfolio centers on the LOQTEQ® platform system, which includes anatomical plates for various body areas (shoulder, elbow, wrist, knee, ankle) and complementary cortical screws. The LOQTEQ® technology combines fracture compression with angle-stable locking in one surgical step. The company also offers two innovative platform technologies: LOQTEQ® antibacterial (silver coating to prevent implant-related infections) and LOQTEQ® resorbable (magnesium implants with hydroxylapatite coating that dissolve after healing). Additional products include ReproBone® bone substitute. The portfolio is protected by international patents and holds regulatory approvals including CE, FDA, NMPA, and ANVISA.
Differentiator
Problem solved
Functional benefit
Brands
- LOQTEQ®: Anatomical plate system for trauma surgery, covering over 95% of relevant indications in trauma surgery of upper and lower extremities. Includes LOQTEQ antibacterial (silver-coated implants) and LOQTEQ resorbable (magnesium-based implants) variants.
- LOQTEQ® antibacterial
- LOQTEQ® resorbable
- ReproBone®
Products and services
- LOQTEQ Plattensystem Anatomical plate system for trauma surgery covering upper and lower extremities with angle-stable locking compression technology. The platform combines fracture compression and angle-stable locking in one surgical step, covering more than 95% of all relevant indications in trauma surgery of the shoulder, elbow, wrist, knee, and ankle. Sold to hospitals, purchasing groups, and network clinics in Germany via direct sales and internationally via distributors.
- LOQTEQ antibacterial Next-generation trauma implants featuring silver coating technology that protects implants from bacterial colonization and patients from implant-related infections, one of the most critical complications of orthopedic and surgical procedures. Clinical human study successfully completed August 2025; MDR and FDA approvals in progress.
- LOQTEQ resorbable Resorbable magnesium implant technology with hydroxylapatite coating that enables trauma implants to be broken down in the body after fracture healing, avoiding a second surgery for implant removal. Platform technology targeting facial surgery, sports medicine, and pediatrics applications.
- Lochschrauben (Cortical Screws) Comprehensive range of cortical screws complementing the LOQTEQ plate system for trauma surgery applications of the upper and lower extremities.
- ReproBone Trauma-complementary bone substitute biomaterial marketed through the distributor network globally.
Quantifiable outcome
- LOQTEQ® portfolio covers >95% of relevant indications in trauma surgery of upper and lower extremities
- +2 more outcomes
Companies that use aap Implantate AG
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
aap Implantate AG technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
aap Implantate AG partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- aap Implants Inc.coreWholly-owned US subsidiary based in Dover, Delaware, responsible for US market operations. Operates hybrid distribution strategy combining distribution agents with selective direct sales and partnerships with global orthopedics companies.
- MCTeQ GmbHcore100% owned subsidiary based in Berlin, Germany. Part of the aap Group corporate structure.
- MAGIC Implants GmbHcore100% owned subsidiary based in Berlin, Germany. Part of the aap Group corporate structure.
- AEQUOS Endoprothetik GmbHminoraap holds 4.57% participation in AEQUOS Endoprothetik GmbH, suggesting a strategic investment or partnership in the endoprosthetics field.
- Youshi MedicalminorChinese partner for regulatory approval of antibacterial implant technology in China. aap plans to pursue approval in China together with Youshi Medical.
- International Distributor NetworkcoreBroad network of distribution partners in approximately 25-41 countries marketing trauma products and trauma-complementary biomaterials worldwide. Actively seeking new distribution partners globally.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
aap Implantate AG competitors and assessment
Company assessmentBroad incumbents
- Stryker Corporation: Stryker operates one of the world's largest orthopedic trauma businesses (formerly Stryker Trauma) offering plates, screws, and intramedullary nails across all major extremities. As a dominant incumbent, it competes with aap across the same trauma surgery indications and hospital purchasing channels.
- Smith+Nephew: Smith+Nephew operates a global trauma and extremities business with plating systems and sports medicine adjacencies. It is a relevant incumbent competitor for aap's trauma plates and screws portfolio in EU and international markets.
- Arthrex: Arthrex is a privately-held global leader in sports medicine, orthopedics, and trauma extremity devices, including plates, screws, and soft-tissue anchors. Its extremities portfolio directly overlaps with aap's LOQTEQ wrist, elbow, and ankle indications.
- DePuy Synthes (Johnson & Johnson): DePuy Synthes is the largest global player in orthopedic trauma, offering comprehensive plate and screw systems across extremities. Its extensive product portfolio, surgeon training programs, and hospital contracts directly overlap with aap's LOQTEQ addressable market.
- Zimmer Biomet: Zimmer Biomet is a leading global orthopedic company with a broad trauma and extremities portfolio including plates, screws, and biologics. Its global scale and trauma sales force compete head-to-head with aap in hospital tenders and surgeon adoption.
- Integra LifeSciences: Integra LifeSciences offers a portfolio of orthopedic extremity hardware, neurosurgical, and regenerative tissue products. Its extremities fixation and specialty orthopedics lines compete with aap in selected trauma and reconstructive indications globally.
- Aesculap (B. Braun): B. Braun's Aesculap division is a major European-headquartered orthopedic and trauma player with plate/screw systems for extremities. As a German-headquartered peer with strong hospital penetration in EMEA, it competes with aap most directly in its home market.
Direct peers
- Orthofix Medical: Orthofix is a global medical device company focused on spine and orthopedic trauma, with a portfolio of plates, screws, and biologics directly comparable to aap's LOQTEQ trauma platform. As a similarly-sized, publicly-listed trauma-focused company, it is the closest analog in scale and product mix.
- Acumed: Acumed is a privately-held orthopedic device company specializing in trauma and extremities implants, including plate and screw systems for upper and lower extremities. Its focused product portfolio and similar scale make it a close comparable for aap's trauma business.
Emerging players
- ITS (Implant Technology Systems) / Paragon 28: Paragon 28 is a smaller publicly-traded orthopedic company focused on foot and ankle extremities, an indication area directly served by aap's LOQTEQ Sprunggelenk (ankle) plates. It represents an emerging competitor in the extremities sub-segment where aap competes.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
aap Implantate AG social profiles
Digital presenceaap Implantate AG compliance and trust
Trust signalCompliance5 records
aap Implantate AG financial estimates
Financial estimateRevenue estimate
Valuation estimate
aap Implantate AG leadership team
Management profileNumber of profiles
Profiles6 records
aap Implantate AG subsidiaries and ownership
Company hierarchySubsidiaries4 records
aap Implantate AG funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
aap Implantate AG M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about aap Implantate AG
What does aap Implantate AG do?
aap Implantate AG develops, manufactures, and markets trauma surgery products, with its core portfolio built around the patented LOQTEQ anatomical plate system for fractures of the upper and lower extremities (shoulder, elbow, wrist, knee, ankle), complemented by cortical screws (Lochschrauben) and the ReproBone bone substitute biomaterial. The company also develops two next-generation platform technologies: LOQTEQ antibacterial silver-coated implants to prevent implant-related infections and LOQTEQ resorbable magnesium implants that biodegrade after fracture healing.
Is aap Implantate AG a public or private company?
aap Implantate AG is a public company. It is classified as public and is currently operating.
When was aap Implantate AG founded?
aap Implantate AG was founded in 1990. It employs 51 to 100 people.
Where is aap Implantate AG based?
aap Implantate AG is headquartered in Berlin, Germany, in the Europe region.
How does aap Implantate AG make money?
Two revenue lines are on record. Trauma Products - LOQTEQ® Plate System is the primary driver. The others are trauma-Complementary Biomaterials.
Who are aap Implantate AG's main competitors?
Broad incumbents on record are Stryker Corporation, Smith+Nephew, Arthrex, DePuy Synthes (Johnson & Johnson), Zimmer Biomet, Integra LifeSciences and Aesculap (B. Braun). Direct peers are Orthofix Medical and Acumed. ITS (Implant Technology Systems) / Paragon 28 is listed as an emerging player.
Does aap Implantate AG have an API?
No public API is recorded for aap Implantate AG.
What industry is aap Implantate AG in?
aap Implantate AG's product category is Orthopedic Trauma Implants. Its primary akta.pro industry code is HLAHAEAB, Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation). Its NAICS code is 339113 and its SIC code is 3842.